Spectra Systems Corporation
SCTQ
$2.03
$0.35220.93%
| Weiss Ratings | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B | |||
| Rating Factors | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.00 | |||
| Price History | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | 0.00% | |||
| 3-Year Total Return | 3.93% | |||
| 5-Year Total Return | 32.01% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.03 | |||
| 52-Week Low Price | $2.03 | |||
| 52-Week Low Price (Date) | Mar 06, 2025 | |||
| 52-Week High Price (Date) | Mar 06, 2025 | |||
| Valuation | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 145.29M | |||
| Enterprise Value | 152.48M | |||
| Price/Earnings (TTM) | 15.48 | |||
| Earnings Per Share (TTM) | 0.13 | |||
| Earnings Per Share Growth | -22.80% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.22 | |||
| Price/Book (Q) | 3.02 | |||
| Enterprise Value/Revenue (TTM) | 2.44 | |||
| Price | $2.03 | |||
| Enterprise Value/EBITDA (TTM) | 7.55 | |||
| Enterprise Value/EBIT | 9.58 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 49.66M | |||
| Dividend Yield | 5.70% | |||
| Div. Per Share (Most Recent) | $0.12 | |||
| Dividend Per Share (TTM) | $0.12 | |||
| Payout Ratio (TTM) | 84.95% | |||
| Dividend Per Share (Most Recent) | $0.12 | |||
| Company Info | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 401 274 4700 | |||
| Address | 40 Westminster Street Providence, RI 02903 | |||
| Website | www.spsy.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 25.49% | |||
| Profit Margin | 20.96% | |||
| Management Effectiveness | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 10.14% | |||
| Return on Equity | 21.52% | |||
| Income Statement | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 31.41M | |||
| Total Revenue (TTM) | 31.41M | |||
| Revenue Per Share | $0.63 | |||
| Gross Profit (TTM) | 18.29M | |||
| EBITDA (TTM) | 10.15M | |||
| EBIT (TTM) | 8.01M | |||
| Net Income (TTM) | 6.59M | |||
| Net Income Avl. to Common (TTM) | 6.59M | |||
| Total Revenue Growth (Q YOY) | 95.67% | |||
| Earnings Growth (Q YOY) | 11.56% | |||
| EPS Diluted (TTM) | 0.13 | |||
| EPS Diluted Growth (Q YOY) | 8.80% | |||
| Balance Sheet | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.44M | |||
| Cash Per Share (Q) | $0.09 | |||
| Total Current Assets (Q) | 27.13M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 33.08M | |||
| Current Ratio (Q) | 1.928 | |||
| Book Value Per Share (Q) | $0.67 | |||
| Total Assets (Q) | 61.38M | |||
| Total Current Liabilities (Q) | 14.07M | |||
| Total Debt (Q) | 10.94M | |||
| Total Liabilities (Q) | 28.30M | |||
| Total Common Equity (Q) | 32.51M | |||
| Cash Flow | SCTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -8.71M | |||
| Cash from Financing (TTM) | -6.80M | |||
| Net Change in Cash (TTM) | -12.14M | |||
| Levered Free Cash Flow (TTM) | -1.03M | |||
| Cash from Operations (TTM) | 3.37M | |||
